Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > Simply Wall Street fair value for MBX $5.74
View:
Post by RazeKreations on Oct 09, 2022 4:56pm

Simply Wall Street fair value for MBX $5.74

This information was extracted from Simply Wall Street Oct/9 2022...................................Share Price vs Fair Value
What is the Fair Price of MBX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MBX (CA$0.51) is trading below our estimate of fair value (CA$5.74)............................
 
Significantly Below Fair Value: MBX is trading below fair value by more than 20%.
Earnings vs Savings Rate: MBX's forecast earnings growth (29.4% per year) is above the savings rate (1.6%).............................
 
Earnings vs Market: MBX's earnings (29.4% per year) are forecast to grow faster than the Canadian market (7.1% per year)...........................
 
High Growth Earnings: MBX's earnings are expected to grow significantly over the next 3 years...................................
 
Revenue vs Market: MBX's revenue (33.7% per year) is forecast to grow faster than the Canadian market (5.8% per year)............................
 
High Growth Revenue: MBX's revenue (33.7% per year) is forecast to grow faster than 20% per year.............................
Debt Level: MBX has more cash than its total debt.
 
Reducing Debt: MBX's debt to equity ratio has reduced from 42.8% to 19.3% over the past 5 years.
 
Debt Coverage: MBX's debt is well covered by operating cash flow (103.2%).
 
Interest Coverage: MBX's interest payments on its debt are well covered by EBIT (3.1x coverage).
Comment by rjc7 on Oct 10, 2022 9:20am
These are amazing stats.  Begs the question why we are only trading at $0.51.  Why does the rest of the market not see it though.  Why does it not recognize even half of its potential. Something is drastically wrong.
Comment by wizzdumb on Oct 10, 2022 10:33am
I think many of us have been saying that for a while. If you believe it it is still available right now for 51 cents. The market is not perfect and can take significant time to recognize its errors. The key is to exploit the gap between undervaluing and realizing, which is now. 
Comment by rjc7 on Oct 11, 2022 12:48pm
At $5.74 they'd be valuing the company at circa $790,000,000.  They're not that big!
Comment by Mbxwatcher on Oct 11, 2022 1:04pm
True....but tell me you didn't multiply that number by the number of shares you own I know I did
Comment by rjc7 on Oct 11, 2022 3:47pm
HAHAHA.  I sure did.  Then I went to bed and had pleasant dreams. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities